Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Apelin ELISA Kit (AC2420)
Cat.#: ASET-1009
Specifications
Description Rat Apelin ELISA Kit is a competitive Enzyme-Linked Immunosorbent Assay (cELISA) designed for the in vitro quantitative determination of rat Apelin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1492 Human GABARAPL1 ELISA Kit (AC2903) Quantitative inquiry ASET-2257 GABA ELISA Kit (AC3668) Quantitative inquiry ASET-2146 Human PTF1A ELISA Kit (AC3557) Quantitative inquiry ASET-2459 Mouse ATG9A ELISA Kit (AC3870) Quantitative inquiry ASET-2314 Human TNF Receptor II ELISA Kit (AC3725) Quantitative inquiry ASET-2478 Human RAMP1 ELISA Kit (AC3889) Quantitative inquiry ASET-1125 Human APH1A ELISA Kit (AC2536) Quantitative inquiry ASET-1081 Human Galectin 7 ELISA Kit (AC2492) Quantitative inquiry ASET-1289 Human Semaphorin 3E ELISA Kit (AC2700) Quantitative inquiry ASET-1104 Human Plexin A2 ELISA Kit (AC2515) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket